These findings are consistent with the recent observation that CD24− cells isolated from breast cancer tissues display a mesenchymal phenotype attributable to the activation of TGFβ and Wnt signaling [30], two pathways known to be involved in EMT [31]. This evidence concerns the gene TGFB1 and breast cancer.